Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models

SIMPLE SUMMARY: Pancreatic ductal adenocarcinoma (PDAC) patient care lacks well-established molecular characterization of the tumors, which would allow for better-personalized treatment selection if improved. To overcome this problem, preclinical models are frequent-ly adopted tools used to elucidat...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Hoare, Owen, Fraunhoffer, Nicolas, Elkaoutari, Abdessamad, Gayet, Odile, Bigonnet, Martin, Roques, Julie, Nicolle, Rémy, McGuckin, Colin, Forraz, Nico, Sohier, Emilie, Tonon, Laurie, Wajda, Pauline, Boyault, Sandrine, Attignon, Valéry, Tabone-Eglinger, Séverine, Barbier, Sandrine, Mignard, Caroline, Duchamp, Olivier, Iovanna, Juan, Dusetti, Nelson J.
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8161239/
https://ncbi.nlm.nih.gov/pubmed/34069519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13102473
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires